Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Eledon Pharmaceuticals, Inc. (ELDN)

Compare
2.9900
-0.0100
(-0.33%)
At close: April 17 at 4:00:02 PM EDT
2.9900
0.00
(0.00%)
After hours: April 17 at 4:05:10 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
70,577
70,577
43,000
39,780
36,867
Operating Income
-70,577
-70,577
-43,000
-39,780
-36,867
Other Income Expense
34,824
34,824
-73,537
-48,186
7
Pretax Income
-35,753
-35,753
-116,537
-87,966
-36,860
Tax Provision
431
431
--
--
-2,354
Net Income Common Stockholders
-36,184
-36,184
-116,537
-87,966
-34,506
Diluted NI Available to Com Stockholders
-36,184
-36,184
-116,537
-87,966
-34,506
Basic EPS
-0.75
--
-4.73
-6.16
-2.33
Diluted EPS
-0.75
--
-4.73
-6.16
-2.33
Basic Average Shares
48,543.7870
--
24,619.1970
14,285.2540
14,819.5820
Diluted Average Shares
48,543.7870
--
24,619.1970
14,285.2540
14,819.5820
Total Operating Income as Reported
--
--
-43,000
-88,428
-36,867
Total Expenses
70,577
70,577
43,000
39,780
36,867
Net Income from Continuing & Discontinued Operation
-36,184
-36,184
-116,537
-87,966
-34,506
Normalized Income
-60,595
-60,595
-40,326
-39,318
-34,506
EBIT
-70,577
-70,577
-43,000
-39,780
-36,867
EBITDA
-70,218
-70,218
-42,626
-39,407
-36,672
Reconciled Depreciation
359
359
374
373
195
Net Income from Continuing Operation Net Minority Interest
-36,184
-36,184
-116,537
-87,966
-34,506
Total Unusual Items Excluding Goodwill
30,900
30,900
-76,211
-48,648
--
Total Unusual Items
30,900
30,900
-76,211
-48,648
--
Normalized EBITDA
-101,118
-101,118
33,585
9,241
-36,672
Tax Rate for Calcs
0.0002
0.0002
--
--
0.0001
Tax Effect of Unusual Items
6,489
6,489
--
--
--
12/31/2021 - 9/17/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XBIT XBiotech Inc.
2.9400
-0.68%
 
DSGN Design Therapeutics, Inc.
3.5000
+3.55%
 
OLMA Olema Pharmaceuticals, Inc.
4.4200
+3.76%
 
KLRS Kalaris Therapeutics, Inc.
6.99
+4.33%
 
OSTX OS Therapies Incorporated
1.5300
-2.55%
 
AURA Aura Biosciences, Inc.
5.36
-0.74%
 
ENTA Enanta Pharmaceuticals, Inc.
5.10
+3.45%
 
TCRX TScan Therapeutics, Inc.
1.4400
+10.77%
 
ABOS Acumen Pharmaceuticals, Inc.
0.9008
-8.08%
 
DMAC DiaMedica Therapeutics Inc.
3.5400
+2.02%